CYP2B6 and metabolic dysfunction-associated steatotic liver disease: However, in this study HFD-fed hCYP2B6-Tg male mice simultaneously increased hepatic triglycerides and glucose tolerance compared to Cyp2b-null mice, which is unusual but not unprecedented [105] as other studies have shown that acute NAFLD can be protective [106].